Cargando…

Epstein–Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function

Natural killer (NK) cells control viral infection through the interaction between inhibitory receptors and human leukocyte antigen (HLA) ligands and bound peptide. NK cells expressing the inhibitory receptor NKG2A/CD94 recognize and respond to autologous B cells latently infected with Epstein–Barr v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mbiribindi, Berenice, Pena, Josselyn K., Arvedson, Matthew P., Moreno Romero, Claudia, McCarthy, Sarah R., Hatton, Olivia L., Esquivel, Carlos O., Martinez, Olivia M., Krams, Sheri M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673117/ https://www.ncbi.nlm.nih.gov/pubmed/33203899 http://dx.doi.org/10.1038/s41598-020-76344-3

Ejemplares similares

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus
por: Hatton, Olivia, et al.
Publicado: (2016)

Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV)+ B Cell Lymphomas
por: Hatton, Olivia, et al.
Publicado: (2012)

Epstein-Barr Virus Latent Membrane Protein 1 Regulates Host B Cell MicroRNA-155 and Its Target FOXO3a via PI3K p110α Activation
por: Hatton, Olivia, et al.
Publicado: (2019)

Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets
por: Glass, Marla C., et al.
Publicado: (2022)

Epstein–Barr virus latent genes
por: Kang, Myung-Soo, et al.
Publicado: (2015)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ
por: Jud, Aurelia, et al.
Publicado: (2016)

Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation
por: Ito, Takuto, et al.
Publicado: (2014)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization
por: Hadad, Uzi, et al.
Publicado: (2015)

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations
por: Fox, Christopher P, et al.
Publicado: (2011)

NK Cell Influence on the Outcome of Primary Epstein–Barr Virus Infection
por: Chijioke, Obinna, et al.
Publicado: (2016)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
por: Ai, Junhong, et al.
Publicado: (2018)

Reactivation of Epstein-Barr Virus Hepatitis in T/Natural Killer (NK) Cells Mimicking Liver T/NK-Cell Lymphoma
por: Kwong, Sara, et al.
Publicado: (2020)

Spatial Clustering of Receptors and Signaling Molecules Regulates NK Cell Response to Peptide Repertoire Changes
por: Mbiribindi, Berenice, et al.
Publicado: (2019)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
por: Soo Hoo, Wesley I., et al.
Publicado: (2023)

Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
por: McCarthy, Michael T., et al.
Publicado: (2019)

Corrigendum: Spatial Clustering of Receptors and Signaling Molecules Regulates NK Cell Response to Peptide Repertoire Changes
por: Mbiribindi, Berenice, et al.
Publicado: (2019)

High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma
por: Ryan, Julie L., et al.
Publicado: (2008)

ZEB1 Regulates the Latent-Lytic Switch in Infection by Epstein-Barr Virus
por: Yu, Xianming, et al.
Publicado: (2007)

Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma
por: Vrzalikova, Katerina, et al.
Publicado: (2018)

Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus
por: Kim, Kyoung-Dong, et al.
Publicado: (2020)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

Prognostic Role of the Expression of Latent-Membrane Protein 1 of Epstein–Barr Virus in Classical Hodgkin Lymphoma
por: Santisteban-Espejo, Antonio, et al.
Publicado: (2021)

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features
por: Kawamoto, Keisuke, et al.
Publicado: (2018)

Predictors of Epstein-Barr virus serostatus in young people in England
por: Winter, Joanne R., et al.
Publicado: (2019)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
por: Bahri, Racha, et al.
Publicado: (2022)

MicroRNA Profiling of Epstein-Barr Virus-Associated NK/T-Cell Lymphomas by Deep Sequencing
por: Motsch, Natalie, et al.
Publicado: (2012)

Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis
por: Fei, Qian, et al.
Publicado: (2018)

One method to establish Epstein‐Barr virus‐associated NK/T cell lymphoma mouse models
por: Xue, Weili, et al.
Publicado: (2018)

Epstein–Barr virus and multiple sclerosis: moving from questions of association to questions of mechanism
por: Thomas, Olivia G, et al.
Publicado: (2023)

NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
por: Murad, Shafiq, et al.
Publicado: (2022)

Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56(dim)NKG2A(+)KIR(−) NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder
por: Lam, Janice K. P., et al.
Publicado: (2020)

Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis
por: Thomas, Olivia G., et al.
Publicado: (2023)

The NK cell checkpoint NKG2A maintains expansion capacity of human NK cells
por: Kaulfuss, Meike, et al.
Publicado: (2023)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Cannot write session to /tmp/vufind_sessions/sess_gshlbbncfouqvtifi0pha8d8bl